Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells - PubMed (original) (raw)
. 1990 Nov 15;348(6298):252-4.
doi: 10.1038/348252a0.
Affiliations
- PMID: 1700304
- DOI: 10.1038/348252a0
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
O Rötzschke et al. Nature. 1990.
Abstract
Virus-infected cells can be eliminated by cytotoxic T lymphocytes (CTL), which recognize virus-derived peptides bound to major histocompatibility complex (MHC) class I molecules on the cell surface. Until now, this notion has relied on overwhelming but indirect evidence, as the existence of naturally processed viral peptides has not been previously reported. Here we show that such peptides can be extracted from virus-infected cells by acid elution. Both the naturally processed H-2-Db-restricted and H-2-Kd-restricted peptides from influenza nucleoprotein are smaller than the corresponding synthetic peptides, which have first been used to determine the respective CTL epitopes. As with minor histocompatibility antigens, occurrence of viral peptides seems to be heavily dependent on MHC class I molecules, because infected H-2d cells do not contain the H-2-Db-restricted peptide, and infected H-2b cells do not contain the H-2-Kd-restricted peptide. Our data provide direct experimental proof for the above notion on MHC-associated viral peptides on virus-infected cells.
Comment in
- Antigen presentation. Naturally processed peptides.
Elliott T, Townsend A, Cerundolo V. Elliott T, et al. Nature. 1990 Nov 15;348(6298):195-7. doi: 10.1038/348195a0. Nature. 1990. PMID: 2172837 No abstract available.
Similar articles
- CTL escape viral variants. I. Generation and molecular characterization.
Lewicki H, Tishon A, Borrow P, Evans CF, Gairin JE, Hahn KM, Jewell DA, Wilson IA, Oldstone MB. Lewicki H, et al. Virology. 1995 Jun 20;210(1):29-40. doi: 10.1006/viro.1995.1314. Virology. 1995. PMID: 7793078 - Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein.
Beauverger P, Chadwick J, Buckland R, Wild TF. Beauverger P, et al. Virology. 1994 Aug 15;203(1):172-7. doi: 10.1006/viro.1994.1470. Virology. 1994. PMID: 7518168 - [Antigenic epitopes of influenza virus specific CTL].
Kuroda K, Hosaka Y. Kuroda K, et al. Nihon Rinsho. 1997 Oct;55(10):2670-5. Nihon Rinsho. 1997. PMID: 9360389 Review. Japanese. - T-cell and B-cell responses to viral antigens at the clonal level.
Sherman LA, Vitiello A, Klinman NR. Sherman LA, et al. Annu Rev Immunol. 1983;1:63-86. doi: 10.1146/annurev.iy.01.040183.000431. Annu Rev Immunol. 1983. PMID: 6085789 Review. No abstract available.
Cited by
- Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation.
Juanes-Velasco P, Arias-Hidalgo C, García-Vaquero ML, Sotolongo-Ravelo J, Paíno T, Lécrevisse Q, Landeira-Viñuela A, Góngora R, Hernández ÁP, Fuentes M. Juanes-Velasco P, et al. Int J Mol Sci. 2024 Sep 3;25(17):9564. doi: 10.3390/ijms25179564. Int J Mol Sci. 2024. PMID: 39273511 Free PMC article. - Implications of MHC-restricted immunopeptidome in transplantation.
Zhanzak Z, Cina D, Johnson AC, Larsen CP. Zhanzak Z, et al. Front Immunol. 2024 Jul 5;15:1436233. doi: 10.3389/fimmu.2024.1436233. eCollection 2024. Front Immunol. 2024. PMID: 39035001 Free PMC article. Review. - Development of NP-Based Universal Vaccine for Influenza A Viruses.
Sayedahmed EE, Elshafie NO, Dos Santos AP, Jagannath C, Sambhara S, Mittal SK. Sayedahmed EE, et al. Vaccines (Basel). 2024 Feb 2;12(2):157. doi: 10.3390/vaccines12020157. Vaccines (Basel). 2024. PMID: 38400140 Free PMC article. - Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations.
Linette GP, Bear AS, Carreno BM. Linette GP, et al. Clin Cancer Res. 2024 May 15;30(10):2017-2024. doi: 10.1158/1078-0432.CCR-23-1212. Clin Cancer Res. 2024. PMID: 38266167 Free PMC article. Review. - Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies.
Goddard ET, Linde MH, Srivastava S, Klug G, Shabaneh TB, Iannone S, Grzelak CA, Marsh S, Riggio AI, Shor RE, Linde IL, Guerrero M, Veatch JR, Snyder AG, Welm AL, Riddell SR, Ghajar CM. Goddard ET, et al. Cancer Cell. 2024 Jan 8;42(1):119-134.e12. doi: 10.1016/j.ccell.2023.12.011. Cancer Cell. 2024. PMID: 38194912
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous